There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| Ask | Qty | Orders |
|---|---|---|
| 8349 | 13 | 314 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
Annual Revenue,rose 13.95%, in the last year to ₹11,067 Cr. Its sector's average revenue growth for the last fiscal year was 12.13%.Annual Net Profit,rose 17.21% in the last year to ₹2,568 Cr. Its sector's average net profit growth for the last fiscal year was 1.9%.Quarterly Revenue,rose 27.8% YoY to ₹3,144 Cr. Its sector's average revenue growth YoY for the quarter was 15.69%.
Divi’s Laboratories Limited, founded in 1990 and headquartered in Hyderabad, is one of the world’s leading manufacturers of active pharmaceutical ingredients (APIs). Its core businesses span Generic APIs, Custom Synthesis for innovator pharma companies, and Nutraceutical ingredients. Divi’s serves customers in over 100 countries, working with 12 of the world’s top 20 pharmaceutical companies.
The company is among the top three global API makers and the largest producer of 10 out of 30 APIs in its portfolio. Its nutraceuticals division manufactures carotenoids and vitamins for dietary supplements, food, beverages, pet food, and feed, with products including Beta Carotene, Astaxanthin, Lycopene, Lutein, and vitamins A, D3, and E Acetate.
Divi’s operates three large manufacturing campuses across Telangana and Andhra Pradesh, supported by three R&D centers and overseas subsidiaries in the USA (New Jersey) and Switzerland (Basel).
Exports accounted for 88% of FY25 revenue, reflecting Divi’s global scale.
Geographic Revenue (FY25 standalone): Europe ₹5,192 crore (56%), North America ₹1,488 crore (16%), Asia ₹1,044 crore (11%), India ₹1,105 crore (12%), Rest of World ₹367 crore (4%).
Over the last 6 months, Divis Laboratories Ltd has given a return of 39.23%. The stock was priced at ₹6,024.50 on 06 Feb 2026 and has Rise to ₹8,349.00 as of 06 Aug 2026, a change of ₹2,324.50 per share.
The intraday low for Divis Laboratories Ltd on the NSE today was ₹8,243.00. The stock's 52-week low stands at ₹5,636.50, recorded on 29 Sep 2025. Today's low is 46.24% above the 52-week low, indicating the stock is trading well above its yearly lows.
Divis Laboratories Ltd has delivered a return of 25.16% over the last 3 months. The stock was trading at ₹6,702.00 on 06 May 2026 and is currently at ₹8,349.00 as of 06 Aug 2026, reflecting a Gain of ₹1,647.00 per share over this period.
Yes,Divis Laboratories Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 150.00 per share between FY2022 and FY2026, with the most recent dividend of ₹30.00 per share for May 26, with an ex-dividend date of 24 Jul 2026. At the current market price of ₹8,349.00, the trailing dividend yield of Divis Laboratories Ltd stands at 60.00%.
Divis Laboratories Ltd has delivered a 70.63% absolute return over the past 5 years, equivalent to a CAGR of 11.28% per annum. The stock was priced at ₹4,893.04 in Aug 2021 and has risen to ₹8,349.00 as of 06 Aug 2026. An investment of ₹1,00,000 in Divis Laboratories Ltd five years ago would be worth ₹1,70,630.00 today.
The all-time high (ATH) for Divis Laboratories Ltd was ₹8,585.00, recorded on 03 Aug 2026. At the current price of ₹8,349.00, the stock is trading 2.75% below its all-time high. The all-time low recorded was ₹282.60 on 05 Feb 2010.
Divis Laboratories Ltd has delivered 36.76% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹8,585.00 on 03 Aug 2026 and a 52-week low of ₹5,636.50 on 29 Sep 2025. It is currently trading at ₹8,349.00 as of 06 Aug 2026.
As of 06 Aug 2026, the share price of Divis Laboratories Ltd is ₹8,349.00 on the NSE and ₹8,291.55 on the BSE. The stock opened at ₹8,408.00, touched a high of ₹8,460.50 and a low of ₹8,243.00 during today's session.
The intraday high for Divis Laboratories Ltd on the NSE today (06 Aug 2026) was ₹8,460.50. This compares to the 52-week high of ₹8,585.00 recorded on 03 Aug 2026. Today's high was -1.45% below the 52-week high.
For Q1 FY27, Divis Laboratories Ltd reported: Revenue (Net Sales): ₹29740.00 Cr - Up 6.48% year-on-year from ₹27930.00 Cr in Q4 FY26. Net Income (PAT): ₹8910.00 Cr - Up 17.86% year-on-year from ₹7560.00 Cr in Q4 FY26.
